Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Nasal Ointment for Epistaxis in HHT
NCT03152019Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- May 2017
- Primary completion
- Nov 2018
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Envarsus XR in hereditary hemorrhagic telangiectasia (HHT), sponsored by Hospices Civils de Lyon. Started May 2017; status: completed.
02
Drugs
Envarsus XR
03
Conditions
hereditary hemorrhagic telangiectasia (HHT)
Beyond the preview
Go deeper on NCT03152019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03152019.